Abstract:Background/Objectives: Phyllanthus species are renowned in traditional medicine for their diverse therapeutic properties, including potential anticancer activities. This study explored the antiproliferative potential of six Phyllanthus species by integrating chemical composition with bioactivity assays to identify key antiproliferative compounds. Methods: The integration of liquid chromatography–mass spectrometry (LC-MS)-based chemical composition data with antiproliferative activity against three cancer cell lines—PC-3 (prostate adenocarcinoma), SiHa (cervical carcinoma), and A549 (lung carcinoma)—as well as a normal mouse fibroblast line (L929) was performed by covariate analysis. These compounds were subsequently isolated and structurally characterized using spectroscopic methods. Results: Through covariate statistics, seven m/z features were found to be plausible active compounds, and after isolation, they were related to butyrolactone and arylnaphthalide lignans. Among the active isolates, an unreported compound, (+)-phyllanlathyrin 6, was discovered in the aerial part of Phyllanthus lathyroides. The isolated compounds exhibited moderate to good antiproliferative activity (IC50 < 20 μM) with selectivity to SiHa, validating the covariate-based identification approach. Conclusions: These findings highlight the potential of Phyllanthus species as sources of novel anticancer agents, with specific arylnaphthalide lignans showing promising cytotoxic effects that could be further developed into therapeutic leads. Additionally, this study underscores the value of combining advanced analytical techniques with bioactivity testing to uncover bioactive compounds from natural sources. The results contribute to the growing body of evidence supporting the therapeutic relevance of Phyllanthus species and provide a foundation for future drug development efforts targeting cancer treatment.

New Cytotoxic Lignan Glycosides from Phyllanthus Glaucus

Phyllanacidins A–C, three new cleistanthane diterpenoids from Phyllanthus acidus and their cytotoxicities

New Phenolic Glycosides from Phyllanthus Cochinchinensis

Phenylacetylene-bearing 3,4-Seco-cleistanthane Diterpenoids from the Roots of Phyllanthus Glaucus.

Enantiomeric Lignans and Neolignans from Phyllanthus Glaucus : Enantioseparation and Their Absolute Configurations

First Total Synthesis of the Bioactive Arylnaphthyl Lignan 4‐o‐glycosides Phyllanthusmin D and 4′′‐o‐acetylmananthoside B

New ent-Kaurane and cleistanthane diterpenoids with potential cytotoxicity from Phyllanthus acidus (L.) Skeels

Phyllaciduloids A-D: Four new cleistanthane diterpenoids from Phyllanthus acidus (L.) Skeels.

Triterpenoid Saponin and Lignan Glycosides from the Traditional Medicine Elaeagnus angustifolia Flowers and Their Cytotoxic Activities

Highly Oxygenated Limonoids and Lignans from Phyllanthus flexuosus.

A New Phenylpropanoid Glycosides from Paris Polyphylla Var. Yunnanensis.

Chemical Composition and Bioactivity Dataset Integration to Identify Antiproliferative Compounds in Phyllanthus Plants

Two novel lignans from Gaultheria yunnanensis.

Isolation and identification of three new phenylpropanoids from the culms of phyllostachys nigra var. henonis (mitford) Rendle

Chemical Constituents from the Thorns of Gleditsia Sinensis and Their Cytotoxic Activities

Two New Lignans Fromphryma Leptostachyal.

Phyllanretiosides A and B: Two Undescribed Compounds from Phyllanthus reticulatus with Nitric Oxide Production Inhibition and Antimicrobial Activity

Cytotoxic and Anti-Inflammatory Prenylated Benzoylphloroglucinols and Xanthones from the Twigs of Garcinia Esculenta

Two New Lignans from Gymnotheca Chinensis Decne

Two New Compounds from Phyllanthus Niruri

A New Phenolic Glycoside from Juglans Mandshurica